| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 7.783.501.560 $ | +557.471.344 $ | +12,5 % | 10 | 7.094.079.357 $ | +1.949.678.728 $ | +57,7 % | 9 | 4.305.304.939 $ | +1.016.480.339 $ | +43,8 % | 6 | ||||
| UNITED THERAPEUTICS Corp | UTHR | → 0 | Neutral | 1.569.833.400 $ | +300.030.665 $ | +23,6 % | 1 | 1.269.802.735 $ | +417.627.050 $ | +49,0 % | 1 | 852.175.685 $ | +171.156.185 $ | +25,1 % | 1 |
| Ascendis Pharma A/S | ASND | → 0 | Schwach | 1.157.945.625 $ | +67.427.315 $ | +6,2 % | 1 | 1.090.518.310 $ | +74.599.210 $ | +7,3 % | 1 | 1.015.919.100 $ | +156.371.100 $ | +18,2 % | 1 |
| MADRIGAL PHARMACEUTICALS, INC. | MDGL | → 0 | Schwach | 951.763.208 $ | -100.816.342 $ | -9,6 % | 1 | 1.052.579.550 $ | +211.855.770 $ | +25,2 % | 1 | 840.723.780 $ | +273.273.780 $ | +48,2 % | 1 |
| ARGENX SE | ARGX | → 0 | Stark | 730.250.000 $ | -102.290.500 $ | -12,3 % | 1 | 832.540.500 $ | +102.356.100 $ | +14,0 % | 1 | 730.184.400 $ | +82.500.900 $ | +12,7 % | 1 |
| Krystal Biotech, Inc. | KRYS | → 0 | Neutral | 746.257.548 $ | +34.031.100 $ | +4,8 % | 1 | 712.226.448 $ | +221.865.474 $ | +45,2 % | 1 | 490.360.974 $ | +124.717.374 $ | +34,1 % | 1 |
| ARROWHEAD PHARMACEUTICALS, INC. | ARWR | → 0 | Schwach | 670.889.937 $ | -34.503.813 $ | -4,9 % | 1 | 705.393.750 $ | +329.452.750 $ | +87,6 % | 1 | 375.941.000 $ | +208.461.000 $ | +124,5 % | 1 |
| Kymera Therapeutics, Inc. | KYMR | → 0 | Schwach | 622.571.678 $ | +40.961.614 $ | +7,0 % | 1 | 581.610.064 $ | +222.200.064 $ | +61,8 % | 1 | ||||
| Apellis Pharmaceuticals, Inc. | APLS | → 0 | 491.699.991 $ | +184.677.774 $ | +60,2 % | 1 | |||||||||
| Structure Therapeutics Inc. | GPCR | → 0 | Neutral | 455.938.850 $ | +309.345.810 $ | +211,0 % | 1 | ||||||||
| Centessa Pharmaceuticals plc | CNTA | → 0 | 454.017.673 $ | +89.983.242 $ | +24,7 % | 1 | |||||||||
| Avidity Biosciences, Inc. | RNA | → 0 | 393.469.150 $ | +60.376.500 $ | +18,1 % | 1 | |||||||||
| Celcuity Inc. | CELC | → 0 | Schwach | 388.272.500 $ | +77.970.289 $ | +25,1 % | 1 | ||||||||
| 7.783.501.560 $ | +557.471.344 $ | +12,5 % | 10 | 7.094.079.357 $ | +1.949.678.728 $ | +57,7 % | 9 | 4.305.304.939 $ | +1.016.480.339 $ | +43,8 % | 6 | ||||